-
EP1621198
European procedure
Extract from the Register of European Patents
EP About this file: EP1621198
| EP1621198 - Substituted carbostyril derivatives as 5-HT 1A receptor subtype agonists [Right-click to bookmark this link] | Status | Patent revoked Status updated on 03.10.2014 Database last updated on 20.11.2024 | Most recent event Tooltip | 16.01.2015 | Lapse of the patent in a contracting state ???moredetails.lapse.edited??? CH, LI | published on 18.02.2015 [2015/08] | Applicant(s) | For all designated states OTSUKA PHARMACEUTICAL CO., LTD. 9, Kandatsukasa-cho 2-chome Chiyoda-ku Tokyo 101-8535 / JP | [2006/05] | Inventor(s) | 01 /
Uwahodo, Yasufumi 70-8, Aza Miyanomae, Oujincho Furukawa Tokushima-shi, Tokushima 771-1151 / JP | 02 /
Jordan, Shaun 3641 Byron Place, Urbana, Frederick Maryland, MD21704 / US | 03 /
Kikuchi, Tetsuro 157-13, Kawauchicho Komatsunishi Tokushima-shi, Tokushima 771-0104 / JP | 04 /
Tottori, Katsura 15-1, Kamirokujo, Kamiitacho Itano-gun, Tokushima 771-1345 / JP | 05 /
Hirose, Tsuyoshi 8-9-502.Sako Ichibancho Tokushima-shi, Tokushima 770-0021 / JP | [2006/05] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [N/P] |
| Former [2008/31] | HOFFMANN EITLE Patent- und Rechtsanwälte Arabellastrasse 4 81925 München / DE | ||
| Former [2006/05] | HOFFMANN EITLE Patent- und Rechtsanwälte Arabellastrasse 4 D-81925 München / DE | Application number, filing date | 05023971.4 | 29.01.2002 | [2006/05] | Priority number, date | US20010770210 | 29.01.2001 Original published format: US 770210 | [2006/05] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP1621198 | Date: | 01.02.2006 | Language: | EN | [2006/05] | Type: | A3 Search report | No.: | EP1621198 | Date: | 12.04.2006 | [2006/15] | Type: | B1 Patent specification | No.: | EP1621198 | Date: | 23.05.2007 | Language: | EN | [2007/21] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 28.02.2006 | Classification | IPC: | A61K31/496, A61K45/06, A61P25/18, A61P25/28 | [2006/43] | CPC: |
A61K31/00 (EP);
A61K31/496 (EP,KR);
A61K45/06 (EP);
A61P1/08 (EP);
A61P15/00 (EP);
A61P15/10 (EP);
A61P25/00 (EP);
A61P25/02 (EP);
A61P25/06 (EP);
A61P25/14 (EP);
A61P25/16 (EP);
A61P25/18 (EP);
A61P25/20 (EP);
A61P25/24 (EP);
A61P25/28 (EP);
A61P25/30 (EP);
A61P25/32 (EP);
A61P3/04 (EP);
| C-Set: |
A61K31/496, A61K2300/00 (EP)
|
| Former IPC [2006/14] | A61K31/00, A61K31/496, A61K45/06, A61P25/24, A61P25/18, A61P25/28, A61P25/16, A61P25/06, A61P25/30, A61P15/00, A61P3/04, A61P1/08 | ||
| Former IPC [2006/05] | A61K31/496, A61P25/18 | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2006/05] | Title | German: | Substituierte Carbostyrilderivate als 5-HT1A-Subtyp Agonisten | [2006/05] | English: | Substituted carbostyril derivatives as 5-HT 1A receptor subtype agonists | [2006/05] | French: | Dérivés substitués de carbostyril comme agonistes du sous-type du récepteur 5-HT1A | [2006/05] | Examination procedure | 03.11.2005 | Examination requested [2006/05] | 27.07.2006 | Amendment by applicant (claims and/or description) | 28.07.2006 | Despatch of a communication from the examining division (Time limit: M04) | 10.08.2006 | Reply to a communication from the examining division | 05.10.2006 | Communication of intention to grant the patent | 22.01.2007 | Fee for grant paid | 22.01.2007 | Fee for publishing/printing paid | Parent application(s) Tooltip | EP02716434.2 / EP1355639 | Divisional application(s) | EP06015782.3 / EP1712225 | Opposition(s) | Opponent(s) | 01
22.02.2008
22.04.2008
ADMISSIBLE Teva Pharmaceutical Industries Ltd. 5 Basel Street, P.O. Box 3190 Petah Tiqva 49131 / IL Opponent's representative Prins, Hendrik Willem, et al, et al Arnold & Siedsma PO Box 18558 2502 EN The Hague / NL | 02
25.02.2008
22.04.2008
ADMISSIBLE STADA Arzneimittel AG Stadastrasse 2-18 61118 Bad Vilbel / DE Opponent's representative Wittkopp, Alexander, et al, et al Maiwald Patentanwalts- und Rechtsanwaltsgesellschaft mbH Jungfernstieg 38 20354 Hamburg / DE | [N/P] |
| Former [2011/02] | |||
| Opponent(s) | 01
22.02.2008
22.04.2008
ADMISSIBLE Teva Pharmaceutical Industries Ltd. 5 Basel Street, P.O. Box 3190 Petah Tiqva 49131 / IL Opponent's representative Prins, Hendrik Willem, et al, et al Arnold & Siedsma PO Box 18558 2502 EN The Hague / NL | ||
| 02
25.02.2008
22.04.2008
ADMISSIBLE STADA Arzneimittel AG Stadastrasse 2-18 61118 Bad Vilbel / DE Opponent's representative Wittkopp, Alexander, et al, et al Maiwald Patentanwalts GmbH Jungfernstieg 38 20354 Hamburg / DE | |||
| Former [2010/02] | |||
| Opponent(s) | 01
22.02.2008
22.04.2008
ADMISSIBLE Teva Pharmaceutical Industries Ltd. 5 Basel Street, P.O. Box 3190 Petah Tiqva 49131 / IL Opponent's representative Prins, Hendrik Willem, et al, et al Bird & Bird LLP P.O. Box 30311 2500 GH Den Haag / NL | ||
| 02
25.02.2008
22.04.2008
ADMISSIBLE STADA Arzneimittel AG Stadastrasse 2-18 61118 Bad Vilbel / DE Opponent's representative Wittkopp, Alexander, et al, et al Maiwald Patentanwalts GmbH Jungfernstieg 38 20354 Hamburg / DE | |||
| Former [2008/15] | |||
| Opponent(s) | 01
22.02.2008
Teva Pharmaceutical Industries Ltd. 5 Basel Street, P.O. Box 3190 Petah Tiqva 49131 / IL Opponent's representative Prins, Hendrik Willem, et al, et al Arnold & Siedsma Sweelinckplein 1 2517 GK The Hague / NL | ||
| 02
25.02.2008
ADMISSIBLE STADA Arzneimittel AG Stadastrasse 2-18 61118 Bad Vilbel / DE Opponent's representative Wittkopp, Alexander, et al, et al Maiwald Patentanwalts GmbH Jungfernstieg 38 20354 Hamburg / DE | |||
| Former [2008/14] | |||
| Opponent(s) | 01
25.02.2008
Stada R & D GmbH Stadastrasse 2 - 18 61118 Bad Vilbel / DE Opponent's representative Wittkopp, Alexander, et al, et al Maiwald Patentanwalts GmbH Jungfernstieg 38 20354 Hamburg / DE | 25.04.2008 | Invitation to proprietor to file observations on the notice of opposition | 31.10.2008 | Reply of patent proprietor to notice(s) of opposition | 18.01.2010 | Date of oral proceedings | 19.02.2010 | Despatch of interlocutory decision in opposition | 19.02.2010 | Despatch of minutes of oral proceedings | 08.07.2014 | Legal effect of revocation of patent [ N /P ] | 08.07.2014 | Legal effect of revocation of patent [2014/45] | 01.09.2014 | Despatch of communication that the patent will be revoked | Appeal following opposition | 28.04.2010 | Appeal received No. T0801/10 | 29.06.2010 | Statement of grounds filed | 08.07.2014 | Result of appeal procedure: revocation of the patent | 16.04.2010 | Appeal received No. T0801/10 | 29.06.2010 | Statement of grounds filed | 08.07.2014 | Result of appeal procedure: revocation of the patent | 08.07.2014 | Date of oral proceedings | 22.07.2014 | Minutes of the oral proceedings despatched | Fees paid | Renewal fee | 24.11.2005 | Renewal fee patent year 03 | 24.11.2005 | Renewal fee patent year 04 | 24.11.2005 | Renewal fee patent year 05 | 25.01.2007 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | CH | 23.05.2007 | LI | 23.05.2007 | [2015/08] |
| Former [2010/16] | deleted | ||
| Former [2009/02] | CY | 29.01.2008 | Documents cited: | Search | [DA]US4734416 (BANNO KAZUO [JP], et al) [DA] 1,2,4-10 * abstract * * column 1, lines 5-60 * * column 2, line 49 - column 3, line 22 * * column 6, lines 41,42 * * column 29, lines 15-24 * * column 33, line 1 * * examples 54,205,233,258,294 * * claims 21,28 *; | [DX]EP0367141 (OTSUKA PHARMA CO LTD [JP]) [DX] 1,2,4-10 * abstract * * page 3, line 4 - line 7 * * page 3, line 29 - line 36 * * example 1 * * claims 12,13,22,23,26-28,31-33 *; | [A]US5691330 (NAKAO TOHRU [JP], et al) [A] 1,2,4-10 * page 2, line 39 - line 67 * * column 3, line 28 - column 4, line 10 *; | [A]WO9938864 (AMERICAN HOME PROD [US]) [A] 1-10 * abstract * * page 1, line 6 - line 11 * * page 6, line 1 * * page 6, line 16 - line 24 *; | [YA] - LIEBERMAN JEFFREY A, "Atypical antipsychotic drugs as a first-line treatment of schizophrenia: A rationale and hypothesis.", JOURNAL OF CLINICAL PSYCHIATRY, (1996), vol. 57, no. SUPPL. 11, ISSN 0160-6689, pages 68 - 71, XP008005973 [Y] 1,2,4-10 * abstract * * tables 2,3 * * page 69, column 2, paragraph 1 - paragraph 2 * * page 70, column 1, paragraph 2 * [A] 1-10 | [YA] - MELTZER H Y ET AL, "SINGLE OR MULTIPLE RECEPTOR TARGETS: WHICH ARE BEST FOR ANTIPSYCHOTIC DRUGS", NEUROPSYCHOPHARMACOLOGY, ELSEVIER SCIENCE PUBLISHING, NEW YORK, NY, US, (200008), vol. 23, no. S02, ISSN 0893-133X, page S73, XP008029267 [Y] 1,2,4-10 [A] 1-10 | [A] - INOUE T ET AL, "EFFECTS OF THE NOVEL ANTIPSYCHOTIC AGENT 7-{4--(2,3-DICHLOROPHENYL)-1 PIPERAZINYL-1-PIPERAZINYLBUTYLOXYü-3,4-DIHYDRO-2(1H)-QUINOLINONE (OPC-14597) ON PROLACTIN RELEASE FROM THE RAT ANTERIOR PITUITARY GLAND", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, AMERICAN SOCIETY FOR PHARMACOLOGY AND, US, (199604), vol. 277, no. 1, ISSN 0022-3565, pages 137 - 143, XP008005978 [A] * page 142, column 1, paragraph L * | [A] - PRINSSEN ERIC P M ET AL, "Interactions between neuroleptics and 5-HT1A ligands in preclinical behavioral models for antipsychotic and extrapyramidal effects.", PSYCHOPHARMACOLOGY, (199905), vol. 144, no. 1, ISSN 0033-3158, pages 20 - 29, XP002209298 [A] 1-6,8 * abstract * * page 20, column 2, paragraph 1 - page 21, column 1, paragraph 2 * * page 25, column 2, paragraph 2 - page 26, column 1, paragraph 1 * * page 26, column 1, paragraph 3 - column 2, paragraph 2 * * page 27, column 1, paragraph 2 - paragraph 3 * * page 27, column 2, paragraph 3 * DOI: http://dx.doi.org/10.1007/s002130050972 | [A] - UWAHODO YASUFUMI ET AL, "Pharmacological profile of OPC-14597, a novel antipsychotic drug (2): Weak extrapyramidal side effects.", JAPANESE JOURNAL OF PHARMACOLOGY, 68th Annual Meeting of the Japanese Pharmacological Society;Nagoya, Japan; March 25-28, 1995, (1995), vol. 67, no. SUPPL. 1, ISSN 0021-5198, page 144P, XP001237224 [A] 1,2,4-10 * the whole document * | [PX] - GARCIA-NANYA M., APIQUIAN R., FRESAN A., "Atypical antipsychotics: Review article [Los antipsycoticos atipicos: Una revision]", SALUD MENTAL, (200110), vol. 24, no. 5, pages 37 - 43, XP008005976 [PX] 1-10 * abstract * * page 38, column 2, paragraph 2 - paragraph 4 * * page 39, column 2, paragraph 4 * | [PA] - JORDAN S ET AL, "IN VIVO EFFECTS OF ARIPIPRAZOLE ON DOPAMINERGIC AND SEROTONERGIC FUNCTION IN RAT PREFRONTAL CORTEX AND STRIATUM", SOCIETY FOR NEUROSCIENCE ABSTRACTS, SOCIETY FOR NEUROSCIENCE, US, (2001), vol. 2, no. 27, ISSN 0190-5295, page 2327,AN87503, XP008005982 [PA] * the whole document * | [PA] - SUMIYOSHI T ET AL, "Tandospirone, a serotonin-1A agonist, added to neuroleptic treatment enhances cognitive performance in schizophrenia", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (2001), Database accession no. PREV200200022926, XP002364564 [PA] * abstract * | [ ] - SOCIETY FOR NEUROSCIENCE ABSTRACTS, 31ST ANNUAL MEETING OF THE SOCIETY FOR NEUROSCIENCE; SAN DIEGO, CALIFORNIA, USA; NOVEMBER 10-15, 2001, (2001), vol. 27, no. 2, ISSN 0190-5295, page 2586 |